Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study
帕博利珠单抗联合化疗对比单纯化疗治疗晚期食管癌:一项随机III期KEYNOTE-590研究的5年延长随访结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105854
Metges, J-P; Kato, K; Sun, J-M; Shen, L; Enzinger, P C; Adenis, A; Doi, T; Kojima, T; Li, Z; Kim, S-B; Cho, B C; Mansoor, W; Li, S-H; Sunpaweravong, P; Alsina, M; Buchschacher, G L Jr; Hara, H; Tsuji, A; Wu, J; Shah, S; Bhagia, P; Shah, M A